Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

10 DIY Jobs to Consider for the New Year

2024 came and went in a flash, and most of us can hardly believe where the time has gone. We had so much planned for the year in terms of DIY and fixing up our homes… but did it all get done? Fear not; a new year is upon us, and now is the perfect time to start planning ahead!   [A person using a drill Description automatically generated]   Here are ten great ideas from property and construction expert Thomas Goodman at MyJobQuote.co.uk  for DIY jobs to complete this year to send your home into 2026 looking fresher than ever before.   Liven

Observe Medical ASA: Mandatory notification of trade

Oslo, 7 January 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 7 January 2025 regarding the approval by the extraordinary general meeting of a share capital increase of NOK 1.30 through the issue of 5 new shares, each with a nominal value of NOK 0.26, in connection with the resolved share consolidation of the Company's shares. Ingerø Reiten Investment Company AS has subscribed for 5 new shares in the Company in said share capital increase. Ingerø Reiten Investment Company AS is represented on

Nordea Bank Abp: Repurchase of own shares on 07.01.2025

Nordea Bank AbpStock exchange release – Changes in company’s own shares07.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 07.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |138,713|10.99 |1,524,650.

Lytix Biopharma AS - Cancellation of Subsequent Offering

Oslo, Norway, 7 January 2025: Reference is made to the stock exchange announcement published by Lytix Biopharma AS ("Lytix" or the "Company") on 17 December 2024 regarding the successful completion of a private placement (the "Private Placement") of new shares raising NOK 100 million in gross proceeds, and a retail offering (the "PrimaryBid Offering") of new shares raising NOK 11.3 million in gross proceeds via the PrimaryBid platform. In the announcement the Company also expressed that it would consider carrying out a subsequent share offering towards existing shareholders in the Company

Buy-back of shares in MTG during week 1, 2025

During the period between 30 December 2024 and 3 January 2025 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 61,581 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors.The share buy-backs form a part of the share repurchase program of a maximum of 5,789,385 shares for a maximum amount of SEK 400 million, which MTG announced on 16 May 2024. The share repurchase program, which runs from 17 May 2024 up until and including 30 April 2025, is being carried out in accordance with the

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 07.01.2025

Fiskars Corporation   Stock Exchange Release 07.01.2025 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 07.01.2025   Date 07.01.2025  Exchange transaction Buy  Share class FSKRS  Amount  2000  Average price/share 14.9721 EURHighest price/share 15.0000 EURLowest price/share 14.9400 EURTotal price 29,944.20 EUR      The share buybacks are executed in compliance with Regulation No. 596/2014 of the European

#25-4 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Inify Laboratories – Registration of prospectus and upcoming launch of Subsequent Offering

STOCKHOLM – 7 January 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 16 December 2024 regarding the successful private placement of 30,202,366 new shares in the Company (the "Private Placement"), and the contemplated subsequent repair offering of 3,464,300 new shares in the Company (the "Subsequent Offering"). The Company has prepared a Norwegian national prospectus for the Subsequent Offering (the "Prospectus"), which was registered with the Norwegian Register of Business Enterprises today, 7 January 2025, in accordance with

Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference

Lund, Sweden, 7 January 2025. Hansa Biopharma AB, “Hansa" or the "Company” (Nasdaq Stockholm: HNSA), today announced that management will attend the 43[rd] Annual J.P. Morgan Healthcare Conference. If you are interested in a meeting, please contact Hansa Biopharma at  ir@hansabiopharma.com. The Company has achieved several key milestones in the last 12-months across its three key therapeutic areas: Autoimmune, Gene Therapy and Transplantation.   In Autoimmune, the company announced positive data from the 15-HMedIdeS-09 Phase 2 trial in Guillain Barre Syndrome (GBS) and indirect

Myth: Black Goku by Gameplay Interactive

Journey into the realm of legend with this vibrant slot game that brings the mythical Monkey King to life. Built on a classic 3x3 layout, this game masterfully blends traditional slot mechanics with rich Asian mythology, creating an immersive experience enhanced by stunning visuals and thoughtful design choices.At the heart of the gameplay lies an elegant reward structure anchored by the Pagoda Wild symbol, which offers an impressive 800x payout for three matches while helping complete other winning combinations. The Monkey King himself makes a majestic appearance as a high-value symbol,

Ecohelix WOODMER Seal Selected as Green Concept Award 2025 Finalist

Over 1500 participants from 45 countries applied for the 12th edition of the Green Product Awards. After being reviewed under the aspects of design, innovation & sustainability, the best submissions were nominated. WOODMER® Seal is one of the Green Concept Award finalists in the Packaging category.WOODMER® Seal is revolutionary fibre-based heat seal coating for packaging. Born from renewable wood biomass, it offers a greener alternative to traditional plastic coatings with emission reduction up to 90%. It´s not just eco-friendly; it´s performance-driven, ensuring strong, reliable heat seal

Nokian Tyres plc: Change in the composition of the Shareholders’ Nomination Board

Nokian Tyres plc Stock Exchange Release January 7, 2025, at 5:00 p.m. EET Solidium Oy has appointed Petter Söderström as a new member of Nokian Tyres' Shareholders' Nomination Board. He will replace Pauli Anttila, who has left Solidium Oy. Nokian Tyres' Shareholders' Nomination Board: • Mr. Petter Söderström (Investment Director, Solidium Oy), appointed by Solidium Oy • Mr. Mikko Mursula (Deputy CEO, Investments, Ilmarinen Mutual Pension Insurance Company), appointed by Ilmarinen Mutual Pension Insurance Company • Ms. Marie Karlsson (Chief Investment Officer, Nordic, Finnish

Observe Medical ASA: Extraordinary general meeting held on 7 January 2025

Oslo, 7 January 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 17 December 2024 regarding notice of an extraordinary general meeting. The extraordinary general meeting was held today, on 7 January 2025 at 10:00 (CET) at the Company's offices in Haakon VIIs gate 1, 7th floor, 0161 Oslo, Norway. The extraordinary general meeting resolved, amongst other, to adopt a consolidation of the Company's shares (reverse share split) in the ratio 15:1 to meet the Oslo Stock Exchange's requirement of a

PixelFox Reports Preliminary Revenue and EBITDA for November 2024

Stockholm, 2025-01-07PixelFox AB (publ) hereby presents its preliminary revenue and EBITDA for November 2024. The preliminary report is published slightly later than usual due to delayed data from external partners.  Period Turnover 2024 EBITDA 2024 Turnover 2023 EBITDA 2023November 2,7 MSEK 0,5 MSEK 3,2 MSEK -0,1 MSEK In November 2024, the Group’s revenue amounted to 2.7 MSEK, representing a moderate decline compared to 3.2 MSEK for the same month in the previous year. At the same time, EBITDA increased to 0.5 MSEK, compared to -0.1 MSEK in November 2023.

Musti Group to enter the Norwegian veterinary market

Musti Group plc                                                             Press Release                    7 January 2025 at 4p.m. Musti Group to enter the Norwegian veterinary market Musti Norge AS, a 100% owned subsidiary of Musti Group plc (“Musti”) has signed a Share Subscription Agreement (SSA) to acquire 40% of Petrus Veterinærer AS (“Petrus”). The transaction was conducted as an issuance of new shares and the key personnel of Petrus are committed to continue developing the company with the strong support from Musti. Petrus operates 2 clinics in the rapidly growing

Joakim Andersson new CFO for Evolution

Evolution AB (publ) today announced that that CFO Jacob Kaplan has decided to step down as CFO. He will be replaced by Joakim Andersson from the 18[th] of February 2025. Jacob Kaplan joined Evolution in 2016 and has been a member of Group Management since then.  He will remain in an advisory role to the company during a period of time. Joakim Andersson (1974) has experience of several CFO roles including listed companies Kinnevik AB (publ) och Cint Group AB (publ). Martin Carlesund, CEO of Evolution said:”I want to thank Jacob for his work and contribution to the development of

GR8 Tech Heads to ICE 2025 with UNbeatable Partnership Announcement

UNbelievable collaboration is coming: GR8 Tech is heading to ICE 2025 with a game-changing partnership announcement set to shake the status quo and push the boundaries of high performance in iGaming. In just two weeks in Barcelona, the mystery will end—and the excitement will begin. Be the first to learn all the details—visit GR8 Tech at stand 4C10.Undisputedly GR8 Collaboration - Teaser  The collaboration will be unveiled at the event from day one, with January 22 marking the official announcement. Save the date and watch when it gets

GomSpace closes 2024 with additional 14MSEK in Power Product orders

GomSpace has been selected as the power systems provider for two leading European space companies, securing product orders worth 14 million SEK. These contracts, awarded just before the close of 2024, highlight the growing demand for GomSpace’s flight-proven, high-reliability power solutions. GomSpace’s Power System Suite simplifies spacecraft power design by offering a fully integrated, flight-proven solution—reducing complexity, accelerating development, and minimizing risk. Combined with GomSpace’s ability to deliver reliable quality and with the right timing, this was a key factor

RaySearch receives first order for DrugLog

RaySearch Laboratories AB (publ) today announces that the Polish company Medim has placed an order for the product DrugLog™. The order is a result of Medim winning a tender from The Children's Memorial Health Institute in Warsaw, Poland.DrugLog is RaySearch's cost-effective solution for quickly and efficiently verifying the identity and concentration of compounded injectable medications used, for example, in cancer treatment with with cytostatic drugs (chemotherapy). DrugLog is used to detect errors in the preparation of drugs, which reduces the risk of medication errors. DrugLog is a

There are no items matching the current filter
There are no more items matching the current filter
Back to top